Methods and compositions for diagnosis and prognosis of renal injury and renal failure

The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more biomarkers selected f...

Full description

Saved in:
Bibliographic Details
Main Authors ANDERBERG JOSEPH, MCPHERSON PAUL, NAKAMURA KEVIN, KAMPF JAMES PATRICK, GRAY JEFF
Format Patent
LanguageChinese
English
Published 07.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more biomarkers selected from the group consisting of Beta-nerve growth factor, Interleukin-17A, Follitropin subunit beta, Collagenase 3, Follistatin, Vitamin D Binding Protein, Islet amyloid polypeptide, Insulin C-peptide, Complement Factor H, Gastric inhibitory polypeptide, Glucagon-like peptide 1, Glucagon, Involucrin, Type II cytoskeletal Keratin- 1/Keratin- 10, Type II cytoskeletal Keratin- 6 A/6B/6C, Osteocalcin, Lipopolysaccharide, Pancreatic prohormone, Peptide YY, Agouti-related protein, Ciliary neurotrophic factor, Appetite-regulating hormone, Transthyretin, Insulin receptor substrate 1,; and NF-kappa-B inhibitor alpha as diagnostic and prognostic biomarker assays in renal injuries.
Bibliography:Application Number: CN201180050168